Cuprina Holdings (Cayman) Ltd. (CUPR)

1.90 -0.05 (-2.56%) USD  |  NASDAQ  |  Oct 16, 16:00
1.86 -0.04 (-2.11%) After-Hours: 20:00
More

Cuprina Holdings Research and Development Expense (Annual) : 0.1736M for Dec. 31, 2025

Research and Development Expense (Annual) Chart

Historical Research and Development Expense (Annual) Data

View and export this data back to 2021. Start Trial.
Date Value
December 31, 2025 0.1736M
December 31, 2024 0.1806M
December 31, 2023 0.1249M
Date Value
December 31, 2022 0.2124M
December 31, 2021 0.2082M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Abbott Laboratories 2.889B
Align Technology, Inc. 369.91M
AngioDynamics, Inc. 29.45M
Accuray, Inc. 37.75M
Alphatec Holdings, Inc. 76.27M